Form 4: Bausch + Lomb Executive Granted 18,253 RSUs

Frederick Munsch, SVP, Controller and CAO of Bausch + Lomb Corporation, was granted 18,253 restricted share units under the company's 2022 Omnibus Incentive Plan.

Summary

• Frederick Munsch, SVP, Controller and CAO of Bausch + Lomb Corp (BLCO), acquired 18,253 common shares in the form of Restricted Share Units (RSUs).
• The transaction date for the grant was February 25, 2026.
• These RSUs were granted under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan.
• The RSUs are scheduled to vest one-third on each of the first three anniversaries of the grant date, subject to continued service.
• Following this transaction, Munsch beneficially owns 108,484 common shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, as it signifies continued executive alignment with shareholder interests through equity incentives, a standard and healthy corporate practice.

Positives

• The grant of Restricted Share Units (RSUs) aligns the interests of a key executive, Frederick Munsch, with those of shareholders, incentivizing long-term performance.
• RSUs are a common and effective tool for executive retention and motivation.

Negatives

• The issuance of new shares upon vesting of RSUs will result in minor dilution for existing shareholders, though the amount of 18,253 shares is relatively small.

Risks

• The value of the RSUs is tied to the future stock price of Bausch + Lomb, meaning the executive's compensation from these units could decrease if the stock price declines.
• The vesting is subject to continued service, meaning the executive must remain employed for the full vesting period to realize the full benefit.

Future Outlook

The future outlook for Frederick Munsch's compensation includes the vesting of 18,253 Restricted Share Units over a three-year period, with one-third vesting on each anniversary of the February 25, 2026 grant date, contingent on his continued service.

Industry Context

StockSavvy.ai notes that the grant of Restricted Share Units (RSUs) is a standard practice in executive compensation across various industries, including pharmaceuticals and medical devices. This method is widely used to align executive incentives with long-term shareholder value creation and to promote executive retention, reflecting common corporate governance trends.

Comparison to Industry Standards

• The use of Restricted Share Units (RSUs) as a component of executive compensation is a prevalent practice among publicly traded companies, including peers in the healthcare and pharmaceutical sectors such as Johnson & Johnson, Pfizer, and Abbott Laboratories.
• The vesting schedule of one-third annually over three years is a common structure designed to encourage long-term commitment and performance, consistent with typical equity incentive plans seen across the S&P 500.
• The grant size for a Senior Vice President, Controller and CAO is generally within expected ranges for a company of Bausch + Lomb's market capitalization, reflecting a standard approach to incentivizing key financial leadership.

Stakeholder Impact

• Shareholders: Minor potential dilution upon vesting, but improved executive alignment and retention.
• Employees: Reinforces the company's commitment to performance-based compensation and executive incentives.

Next Steps

• One-third of the granted RSUs are scheduled to vest on February 25, 2027.
• Another one-third of the granted RSUs are scheduled to vest on February 25, 2028.
• The final one-third of the granted RSUs are scheduled to vest on February 25, 2029.

Key Dates

Recommendation

This Form 4 filing reports a routine executive compensation event (RSU grant) and does not contain information significant enough to alter an investment thesis or warrant a change in recommendation. It primarily indicates ongoing executive incentive alignment, which is generally a neutral to slightly positive factor for a 'hold' position.

Keywords

Bausch + Lomb, BLCO, Form 4, Restricted Share Units, RSUs, Executive Compensation, Insider Transaction, Frederick Munsch, Omnibus Incentive Plan